Neurim Takes Second Shot At Pulling Generic Insomnia Drug
Neurim Pharmaceuticals has launched a second round of litigation against two Viatris Inc. subsidiaries to try and pull a generic version of its insomnia medication off the market, despite a ruling...To view the full article, register now.
Already a subscriber? Click here to view full article